No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
RAPT Therapeutics Partners With Jemincare and Secures Funding
Express News | RAPT Therapeutics Shares More Than Double Premarket on License Agreement for Allergy Treatment
Market-Moving News for December 23rd
RAPT Therapeutics To Raise $150M in Private Placement to Advance Drug Pipeline
Express News | RAPT Therapeutics Announces $150 Million Private Placement
Express News | RAPT Therapeutics Inc - Obtains Worldwide Rights Excluding China